Acetazolamide
Back to searchMolecule Structure
Scientific Name
Acetazolamide
Description of the Drug
Acetazolamide is a carbonic anhydrase inhibitor used to treat edema from heart failure or medications, certain types of epilepsy, and glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00819
http://www.drugbank.ca/drugs/DB00819
Brand Name(s)
Acetazolamide, Diamox, Diamox sr, Eytazox
Company Owner(s)
Sun Pharmaceutical Industries Inc, Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc, Watson Laboratories Inc, Alra Laboratories Inc, Mankind Pharma Ltd, Xgen Pharmaceuticals Djb Inc, Mylan Asi Llc, Emcure Pharmaceuticals Ltd, Zydus Pharmaceuticals Usa Inc, Novitium Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Carbonic anhydrase I | SINGLE PROTEIN | INHIBITOR | CHEMBL261 |
| Carbonic anhydrase II | SINGLE PROTEIN | INHIBITOR | CHEMBL205 |
| Carbonic anhydrase XII | SINGLE PROTEIN | INHIBITOR | CHEMBL3242 |
| Carbonic anhydrase IV | SINGLE PROTEIN | INHIBITOR | CHEMBL3729 |
Clinical Trial(s)
Unichem Links
| Atlas | acetazolamide | ||||||
| SureChEMBL | SCHEMBL23219 | ||||||
| PharmGKB | PA448018 | ||||||
| Human Metabolome Database | HMDB0014957 | ||||||
| DrugBank | DB00819 | ||||||
| PubChem: Thomson Pharma | 15121457 | ||||||
| PubChem | 1986 | ||||||
| Mcule | MCULE-4029778803 | ||||||
| NMRShiftDB | 20209331 | ||||||
| LINCS | LSM-5543 | ||||||
| Nikkaji | J1.395A | ||||||
| PDBe | AZM | ||||||
| BindingDB | 10880 | ||||||
| EPA CompTox Dashboard | DTXSID7022544 | ||||||
| DrugCentral | 56 | ||||||
| Brenda | 26713 | 28452 | 259 | 10840 | 224463 | 22616 | 118358 |
| ChemicalBook | CB82665568 | CB0430959 | |||||
| Guide to Pharmacology | 6792 | ||||||
| rxnorm | DIAMOX | ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE | ||||
| PubChem: Drugs of the Future | 57304369 | ||||||
| KEGG Ligand | C06805 | ||||||
| ChEBI | 27690 | ||||||
| ZINC | ZINC000003813042 |
